Seema Kennedy: The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s Specialist Register to prescribe cannabis-based products for medicinal use (CBPM), where it is clinically appropriate and in the best interest of patients. Whilst the law does not restrict the conditions for which these products may be prescribed, interim guidance has been issued by the Royal College...
Lord Jones of Cheltenham: To ask Her Majesty's Government what plans they have, if any, to extend the availability of medicinal cannabis to people with diseases that cause chronic pain.
Frank Field: To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals on a regulatory category medicinal cannabis.
Gavin Newlands: The SNP also supports the order before us for many reasons, many of which are contained in the fantastic report from the Health and Social Care Committee, “Drugs policy: medicinal cannabis”, published this morning. We support it not least because we believe that, under the current regime, the potential exists for research and investigation into medicinal cannabinoids to be hindered, and...
Andrew Griffiths: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 June 2019 to Question 266815 on Cannabis: Medical Treatments, how many prescriptions for the use of medicinal cannabis were issued in each of the last 12 months for which data is available.
Tonia Antoniazzi: To ask the Secretary of State for Health and Social Care, whether patients whose prescription for a cannabis-based medical product is blocked by an NHS trust can appeal that decision.
Tonia Antoniazzi: ...and Social Care, what recent discussions his Department has had with (a) NHS England, (b) drug manufacturers and (c) the National Institute for Health and Care Excellence on funding for licensed cannabis-based products.
Andrew Griffiths: To ask the Secretary of State for Health and Social Care, how many licences have been issued for the prescription of medicinal cannabis.
Tonia Antoniazzi: In a recently aired BBC Scotland documentary on medical cannabis, the chair of the British Paediatric Neurology Association, Finbar O’Callaghan, said that the NHS will not pay for life-changing medical cannabis for epileptic children, by saying, “Even if you prescribe the product, the NHS isn’t going to pay for it.” Is his statement correct, Prime Minister?
Ian Blackford: To ask the Secretary of State for Health and Social Care, how many companies are licensed to sell cannabis products to the NHS.
Frank Field: To ask the Secretary of State for Health and Social Care, what progress he has made on ensuring that medical cannabis is available to people who need it.
Tonia Antoniazzi: Following my visit to the Netherlands two weeks ago with Emma Appleby, I have witnessed at first hand the incompetence of the Home Office and the Department of Health and Social Care in delivering medical cannabis with THC, not just CBD, for children with severe epilepsy. History was made exactly one year ago today when Alfie Dingley received the licence for his medication and the Prime...
Philippa Whitford: To ask the Secretary of State for Health and Social Care, how and by whom medical cannabis was produced in the UK before its legalisation.
Tonia Antoniazzi: What progress the Government has made on making medical cannabis available to people who need it.
Tonia Antoniazzi: As the Minister will know, two weeks ago I went to the Netherlands with Teagan Appleby’s mother, Emma, to collect one month’s supply of medical cannabis. The Department laid down the requirements for Emma to meet with Border Force, and she met them by providing a UK prescription. Will the Secretary of State and Ministers meet me to ensure that there is no more ambiguity in a policy that...
Mike Penning: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the cost-effectiveness of patients receiving an NHS prescription for wholeplant medical cannabis.
Frank Field: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all patients who would benefit from medical cannabis are able to access that treatment on prescription on the NHS.
Ian Austin: ...State for Health and Social Care, what discussions his Department has had with (a) NHS England, (b) manufacturers and (c) NICE on funding arrangements for accessing (a) licensed and (b) unlicensed cannabis-based medicines on the NHS.
Mike Penning: To ask the Secretary of State for Health and Social Care, which countries his Department is engaging with in order to learn from their experiences in getting patients access to medical cannabis.
Mike Penning: To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care on 20 May 2019, Official Report, column, 571, what plans he has to include observational trials in building up the existing evidence-base.